These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Current controversies on the role of retroperitoneal lymphadenectomy for testicular cancer. Mano R, Di Natale R, Sheinfeld J. Urol Oncol; 2019 Mar 15; 37(3):209-218. PubMed ID: 30446455 [Abstract] [Full Text] [Related]
34. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion. Stephenson AJ, Bosl GJ, Bajorin DF, Stasi J, Motzer RJ, Sheinfeld J. J Urol; 2005 Aug 15; 174(2):557-60; discussion 560. PubMed ID: 16006891 [Abstract] [Full Text] [Related]
35. [Retroperitoneal lymphadenectomy in disseminated non-seminoma germinogenic testicular tumors after chemotherapy in patients with elevated serum tumor markers]. Matveev VB, Volkova MI, Cherniev VA, Figurin KM, Mitin AV. Urologiia; 2010 Aug 15; (3):41-7. PubMed ID: 20734877 [Abstract] [Full Text] [Related]
36. The Role of Postchemotherapy Surgery in Germ Cell Tumors. Chéry L, Dash A. Urol Clin North Am; 2015 Aug 15; 42(3):331-42. PubMed ID: 26216820 [Abstract] [Full Text] [Related]
39. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study. Dusaud M, Malavaud B, Bayoud Y, Sebe P, Hoepffner JL, Salomon L, Houlgatte A, Pignot G, Rigaud J, Fléchon A, Pfister C, Rouprêt M, Soulié M, Méjean A, Durand X. J Surg Oncol; 2016 Dec 15; 114(8):992-996. PubMed ID: 27859263 [Abstract] [Full Text] [Related]
40. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy. Heidenreich A, Pfister D. Arch Esp Urol; 2012 Mar 15; 65(2):215-26. PubMed ID: 22414450 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]